By Erica Teichert Daiichi Sankyo announced it will recall 13 lots in Japan of a Sanofi Pasteur ActHIB vaccine–whose use has been suspended in the country–due to an unidentified substance found in two syringes. Japan officials have cleared the vaccine, and Pfizer’s Prevnar, after investigating the vaccines’ role in six children’s deaths.
Japan halts vaccines from Pfizer, Sanofi after deaths of four children
By Mike Adams, the Health Ranger (NaturalNews) The deaths just keep mounting all across the world: Children are collapsing into comas and then dying, just minutes after receiving combination vaccines that have been deceptively marketed as “completely safe.” Last year, Australia temporarily banned flu vaccines in children after they were found to have caused vomiting, […]
False Advertising of the HPV Vaccines
By Christina England 19 January 2011 A recent news report claims that there has been a spate of false advertising by Merck and GlaxoSmithKline for their HPV vaccines. SANE VAX sent out a press release this week reporting that around the world HPV vaccines have been falsely advertised. They state that as a consequence of […]
U.S. FDA Grants Fast-Track Designation to Sanofli Pasteur's Investigational Clostridium difficile Vaccine
By: Sanofli Pasteur 09 November 2010 SWIFTWATER, Pennsylvania, November 9, 2010 /PRNewswire via COMTEX/ — Sanofi Pasteur, the vaccines division of sanofi-aventis Group , announced today that the U.S. Food and Drug Administration (FDA) has granted fast-track designation to the company’s investigational Clostridium difficile vaccine candidate. The fast-track program of the FDA is designed to […]
BARDA awards contracts for influenza vaccine
By: Paul Purlain 11 October 2010 The U.S. Department of Health and Human Services’ Biomedical Advanced Research Development Authority has announced a new contract worth $57 million to help safeguard the United States in the case of a pandemic influenza outbreak. The contract with French pharmaceutical company Sanofi Pasteur is an extension of an existing […]